Dynamics of clonal evolution in myelodysplastic syndromes H Makishima, T Yoshizato, K Yoshida, MA Sekeres, T Radivoyevitch, ... Nature genetics 49 (2), 204-212, 2017 | 429 | 2017 |
Genetic alterations of the cohesin complex genes in myeloid malignancies S Thota, AD Viny, H Makishima, B Spitzer, T Radivoyevitch, ... Blood, The Journal of the American Society of Hematology 124 (11), 1790-1798, 2014 | 269 | 2014 |
Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis AD Viny, CJ Ott, B Spitzer, M Rivas, C Meydan, E Papalexi, D Yelin, ... Journal of Experimental Medicine 212 (11), 1819-1832, 2015 | 155 | 2015 |
Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms RJ Molenaar, S Thota, Y Nagata, B Patel, M Clemente, B Przychodzen, ... Leukemia 29 (11), 2134-2142, 2015 | 102 | 2015 |
Genomic determinants of chronic myelomonocytic leukemia BJ Patel, B Przychodzen, S Thota, T Radivoyevitch, V Visconte, ... Leukemia 31 (12), 2815-2823, 2017 | 98 | 2017 |
Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL) SR Sanikommu, MJ Clemente, P Chomczynski, MG Afable, A Jerez, ... Leukemia & lymphoma 59 (2), 416-422, 2018 | 95 | 2018 |
Rational management approach to pure red cell aplasia SK Balasubramanian, M Sadaps, S Thota, M Aly, BP Przychodzen, ... Haematologica 103 (2), 221, 2018 | 71 | 2018 |
NCCN Guidelines® insights: myelodysplastic syndromes, version 3.2022: featured updates to the NCCN guidelines PL Greenberg, RM Stone, A Al-Kali, JM Bennett, U Borate, AM Brunner, ... Journal of the National Comprehensive Cancer Network 20 (2), 106-117, 2022 | 68 | 2022 |
Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia B Bilori, S Thota, MJ Clemente, B Patel, A Jerez, M Afable Ii, ... Leukemia 29 (12), 2427-2429, 2015 | 67 | 2015 |
Immune thrombocytopenia in adults: an update S Thota, G Kistangari, H Daw, T Spiro Cleve Clin J Med 79 (9), 641-650, 2012 | 66 | 2012 |
Systemic mastocytosis, version 2.2019, NCCN clinical practice guidelines in oncology J Gotlib, AT Gerds, P Bose, MC Castells, MW Deininger, I Gojo, ... Journal of the National Comprehensive Cancer Network 16 (12), 1500-1537, 2018 | 54 | 2018 |
Inotuzumab ozogamicin in relapsed B‐cell acute lymphoblastic leukemia S Thota, A Advani European journal of haematology 98 (5), 425-434, 2017 | 53 | 2017 |
A clinical review of small-cell carcinoma of the urinary bladder S Thota, G Kistangari, H Daw, T Spiro Clinical genitourinary cancer 11 (2), 73-77, 2013 | 53 | 2013 |
Acute myeloid leukemia, version 3.2023, NCCN clinical practice guidelines in oncology DA Pollyea, JK Altman, R Assi, D Bixby, AT Fathi, JM Foran, I Gojo, ... Journal of the National Comprehensive Cancer Network 21 (5), 503-513, 2023 | 29 | 2023 |
Complete mutational spectrum of the autophagy interactome: A novel class of tumor suppressor genes in myeloid neoplasms V Visconte, B Przychodzen, Y Han, ST Nawrocki, S Thota, KR Kelly, ... Leukemia 31 (2), 505-510, 2017 | 29 | 2017 |
Myeloid/lymphoid neoplasms with eosinophilia and TK fusion genes, version 3.2021, NCCN clinical practice guidelines in oncology AT Gerds, J Gotlib, P Bose, MW Deininger, A Dunbar, A Elshoury, ... Journal of the National Comprehensive Cancer Network 18 (9), 1248-1269, 2020 | 26 | 2020 |
Molecular features of early onset adult myelodysplastic syndrome CM Hirsch, BP Przychodzen, T Radivoyevitch, B Patel, S Thota, ... Haematologica 102 (6), 1028, 2017 | 24 | 2017 |
Myelodysplastic and myeloproliferative neoplasms: updates on the overlap syndromes S Thota, AT Gerds Leukemia & Lymphoma 59 (4), 803-812, 2018 | 20 | 2018 |
Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML B Przychodzen, H Makishima, MA Sekeres, SK Balasubramanian, ... Oncotarget 9 (2), 2050, 2018 | 19 | 2018 |
Mutant PPM1D- and TP53-Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide Therapy A Singh, N Mencia-Trinchant, EA Griffiths, A Altahan, M Swaminathan, ... JCO Precision Oncology 6, e2100309, 2022 | 18 | 2022 |